X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2496) 2496
Publication (212) 212
Book Review (41) 41
Book Chapter (10) 10
Conference Proceeding (6) 6
Book / eBook (4) 4
Dissertation (2) 2
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1716) 1716
oncology (1476) 1476
female (1415) 1415
index medicus (1335) 1335
ovarian cancer (893) 893
cancer (846) 846
chemotherapy (846) 846
middle aged (763) 763
recurrent (703) 703
aged (659) 659
adult (650) 650
ovarian neoplasms - drug therapy (580) 580
obstetrics & gynecology (555) 555
carcinoma (488) 488
recurrent ovarian cancer (372) 372
paclitaxel (371) 371
ovarian neoplasms - pathology (357) 357
antineoplastic combined chemotherapy protocols - therapeutic use (341) 341
treatment outcome (336) 336
care and treatment (325) 325
cisplatin (312) 312
research (302) 302
bevacizumab (299) 299
neoplasm recurrence, local - drug therapy (277) 277
survival (273) 273
phase-ii trial (266) 266
aged, 80 and over (254) 254
surgery (254) 254
antineoplastic agents - therapeutic use (251) 251
medicine & public health (246) 246
phase-ii (245) 245
retrospective studies (243) 243
gynecologic-oncology-group (239) 239
animals (234) 234
carboplatin (231) 231
disease-free survival (231) 231
hematology, oncology and palliative medicine (231) 231
pegylated liposomal doxorubicin (231) 231
male (229) 229
prognosis (228) 228
recurrent epithelial ovarian (227) 227
trial (227) 227
pharmacology & pharmacy (224) 224
health aspects (223) 223
therapy (216) 216
analysis (210) 210
tumors (201) 201
neoplasm staging (199) 199
ovarian-cancer (188) 188
obstetrics and gynecology (186) 186
recurrent ovarian-cancer (183) 183
clinical trials (176) 176
antineoplastic combined chemotherapy protocols - adverse effects (170) 170
ovarian neoplasms - mortality (161) 161
relapse (157) 157
survival rate (153) 153
breast-cancer (151) 151
drug resistance, neoplasm (151) 151
paclitaxel - administration & dosage (150) 150
open-label (148) 148
neoplasm recurrence, local - pathology (145) 145
metastasis (144) 144
topotecan (143) 143
recurrent ovarian (142) 142
phase-iii trial (141) 141
ovarian neoplasms - surgery (140) 140
cell lung-cancer (137) 137
drug therapy (136) 136
endometrial cancer (136) 136
platinum (135) 135
antineoplastic agents (134) 134
article (133) 133
management (131) 131
women (131) 131
cancer therapies (130) 130
carboplatin - administration & dosage (130) 130
ovarian neoplasms - therapy (130) 130
antimitotic agents (129) 129
epithelial ovarian (129) 129
expression (129) 129
mutation (129) 129
patients (129) 129
primary peritoneal (128) 128
oncology, experimental (127) 127
recurrence (125) 125
angiogenesis (124) 124
carcinoma, ovarian epithelial (124) 124
diseases (124) 124
genetic aspects (124) 124
survival analysis (124) 124
antineoplastic agents - administration & dosage (123) 123
drug administration schedule (123) 123
combined modality therapy (122) 122
cytoreductive surgery (122) 122
endothelial growth-factor (121) 121
double-blind (117) 117
fallopian-tube (113) 113
development and progression (111) 111
cervical cancer (109) 109
cancer research (108) 108
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2407) 2407
German (33) 33
French (29) 29
Korean (18) 18
Polish (8) 8
Spanish (8) 8
Italian (4) 4
Japanese (3) 3
Czech (2) 2
Hungarian (2) 2
Russian (2) 2
Romanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Oncology, ISSN 0923-7534, 11/2017, Volume 28, Issue suppl_8, pp. viii51 - viii56
Journal Article
JNCCN Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 01/2011, Volume 9, Issue 1, pp. 82 - 113
Journal Article
International Journal of Gynecological Cancer, ISSN 1048-891X, 05/2011, Volume 21, Issue 4, pp. 771 - 775
Journal Article
Nature Reviews Disease Primers, ISSN 2056-676X, 08/2016, Volume 2, Issue 1, pp. 1 - 22
Ovarian cancer is not a single disease and can be subdivided into at least five different histological subtypes that have different identifiable risk factors,... 
PHASE-III TRIAL | BRCA2 MUTATION CARRIERS | PEGYLATED LIPOSOMAL DOXORUBICIN | MEDICINE, GENERAL & INTERNAL | GRADE SEROUS CARCINOMA | PRIMARY PERITONEAL CANCER | SMALL-CELL CARCINOMA | GROSS RESIDUAL DISEASE | RECURRENT EPITHELIAL OVARIAN | CARBOPLATIN PLUS PACLITAXEL | OLAPARIB MAINTENANCE THERAPY
Journal Article
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, ISSN 1540-1405, 05/2019, Volume 17, Issue 5, pp. 619 - 621
After 3 to 4 decades of stagnation, several new options are available for the treatment of ovarian cancer, some of which produce longer survival compared with... 
TRIAL | ONCOLOGY | BEVACIZUMAB | RECURRENT | DOUBLE-BLIND | MAINTENANCE THERAPY | CHEMOTHERAPY
Journal Article